Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Roche’s Genentech debuts next iteration of MS campaign, highlights experiences in Black community
3 years ago
Marketing
IRA's price negotiation provision would've saved Medicare $26.5B from 2018 to 2020, JAMA study says
3 years ago
Appeals court tosses J&J's controversial 'Texas two-step' bankruptcy case
3 years ago
Law
Oracle executive Troy Tazbaz named new FDA director of digital health
3 years ago
People
FDA+
Updated: $100B+ in savings? Why the incoming Humira biosimilars will take time to catch on
3 years ago
Amgen lays off about 300 workers, citing 'industry headwinds'
3 years ago
People
Bristol Myers, Charles River join Series A funding for iVexSol
3 years ago
Financing
Manufacturing
Updated: Samsung Biologics spells out expansion plans in South Korea and US
3 years ago
Manufacturing
Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma
3 years ago
R&D
Novartis' approved sickle cell disease drug fails to beat placebo in PhIII
3 years ago
R&D
Sen. Elizabeth Warren urges FTC to 'scrutinize' two pharma buyouts
3 years ago
UCB, Novo Nordisk, Gilead rank highest among pharmas for HCP customer experience — survey
3 years ago
Marketing
Novavax gets ready to take another shot at Covid vaccine market with next season plans
3 years ago
FDA+
Post-hoc analysis: EMA's CHMP rejects Ipsen's potential drug for rare genetic disease
3 years ago
FDA+
FDA approves another indication for Keytruda, this time in the adjuvant NSCLC setting
3 years ago
R&D
FDA+
J&J, Legend say Carvykti beat standard therapy in earlier-line blood cancer
3 years ago
R&D
Cell/Gene Tx
Pfizer lays off employees at California and Connecticut sites
3 years ago
People
FDA advisory committee votes unanimously in favor of bivalent Covid shots replacing primary series
3 years ago
FDA+
FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study
3 years ago
FDA+
In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'
3 years ago
Law
'Tis the season: GSK addresses winter virus surges with celebrity and influencer vaccine awareness campaigns
3 years ago
Marketing
Bristol Myers claims win with CAR-T therapy Breyanzi in leukemia
3 years ago
R&D
FDA cuts off use for AstraZeneca’s Covid-19 therapy Evusheld
3 years ago
FDA+
Coronavirus
FDA takes next step in Torrent Pharmaceuticals' troubled India plant saga, issues OAI
3 years ago
FDA+
Manufacturing
First page
Previous page
147
148
149
150
151
152
153
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit